Abstract:Background: The differentiation of pericytes into myofibroblasts causes microvascular degeneration, ECM (extracellular matrix) accumulation, and tissue stiffening, characteristics of fibrotic diseases. It is unclear how pericyte-myofibroblast differentiation is regulated in the microvascular environment. Our previous study established a novel 2-dimensional platform for coculturing microvascular endothelial cells (ECs) and pericytes derived from the same tissue. This study investigated how ECM stiffness regulated microvascular ECs, pericytes, and their interactions. Methods: Primary microvessels were cultured in the TGM2D medium (tubular microvascular growth medium on 2-dimensional substrates). Stiff ECM was prepared by incubating ECM solution in regular culture dishes for 1 hour followed by PBS wash. Soft ECM with Young modulus of ≈6 kPa was used unless otherwise noted. Bone grafts were prepared from the rat skull. Immunostaining, RNA sequencing, RT-qPCR (real-time quantitative polymerase chain reaction), Western blotting, and knockdown experiments were performed on the cells. Results: Primary microvascular pericytes differentiated into myofibroblasts (NG2+αSMA+) on stiff ECM, even with the TGFβ (transforming growth factor beta) signaling inhibitor A83-01. Soft ECM and A83-01 cooperatively maintained microvascular stability while inhibiting pericyte-myofibroblast differentiation (NG2+αSMA-/low). We thus defined 2 pericyte subpopulations: primary (NG2+αSMA-/low) and activated (NG2+αSMA+) pericytes. Soft ECM promoted microvascular regeneration and inhibited fibrosis in bone graft transplantation in vivo. As integrins are the major mechanosensor, we performed RT-qPCR screening of integrin family members and found Itgb1 (integrin β1) was the major subunit downregulated by soft ECM and A83-01 treatment. Knocking down Itgb1 suppressed myofibroblast differentiation on stiff ECM. Interestingly, ITGB1 phosphorylation (Y783) was mainly located on microvascular ECs on stiff ECM, which promoted EC secretion of paracrine factors, including CTGF (connective tissue growth factor), to induce pericyte-myofibroblast differentiation. CTGF knockdown or monoclonal antibody treatment partially reduced myofibroblast differentiation, implying the participation of multiple pathways in fibrosis formation. Conclusions: ECM stiffness and TGFβ signaling cooperatively regulate microvascular stability and pericyte-myofibroblast differentiation. Stiff ECM promotes EC ITGB1 phosphorylation (Y783) and CTGF secretion, which induces pericyte-myofibroblast differentiation.

Increased extracellular matrix stiffness regulates myofibroblast transformation through induction of autophagy-mediated Kindlin-2 cytoplasmic translocation

Structural, Functional and Molecular Pathogenesis of Pelvic Organ Prolapse in Patient and Loxl1 Deficient Mice

Mechanical stress influences the morphology and function of human uterosacral ligament fibroblasts and activates the p38 MAPK pathway

Roles and mechanisms of biomechanical-biochemical coupling in pelvic organ prolapse

Extracellular matrix stiffness regulates the activation of urethral fibroblasts via FAK/ROCK-1/YAP pathway

Mechanical Stretching induces the apoptosis of parametrial ligament Fibroblasts via the Actin Cytoskeleton/Nr4a1 signalling pathway

Mitofusin2 Regulates the Proliferation and Function of Fibroblasts: the Possible Mechanisms Underlying Pelvic Organ Prolapse Development

Single-cell transcriptomic data reveal the increase in extracellular matrix organization and antigen presentation abilities of fibroblasts and smooth muscle cells in patients with pelvic organ prolapse

The polymorphisms of extracellular matrix-remodeling genes are associated with pelvic organ prolapse

The effect of AKT in extracellular matrix stiffness induced osteogenic differentiation of hBMSCs

Keloid fibroblasts have elevated and dysfunctional mechanotransduction signaling that is independent of TGF-β

Tissue stiffness contributes to YAP activation in bladder cancer patients undergoing transurethral resection

Advance on the Pathogenesis of Female Pelvic Floor Dysfunction

Extracellular matrix viscoelasticity regulates TGFβ1-induced epithelial-mesenchymal transition and apoptosis via integrin linked kinase

MP11-11 ACTIVATION OF NFKB-JMJD3 SIGNALING PROMOTES BLADDER FIBROSIS VIA BOOSTING BLADDER SMOOTH MUSCLE CELL PROLIFERATION AND COLLAGEN ACCUMULATION

Potential therapeutic targets for pelvic organ prolapse: insights from key genes related to blood vessel development

FZD3 regulates the viability, apoptosis, and extracellular matrix degradation of vaginal wall fibroblasts in pelvic organ prolapse via the Wnt signaling pathway

The difference in extracellular matrix metabolism in women with and without pelvic organ prolapse: A systematic review and meta‐analysis

Dysregulated microRNAs and long non-coding RNAs associated with extracellular matrix stiffness

Extracellular Matrix Stiffness Regulates Microvascular Stability by Controlling Endothelial Paracrine Signaling to Determine Pericyte Fate

Advanced Glycation End Products Decrease Collagen I Levels in Fibroblasts from the Vaginal Wall of Patients with POP Via the RAGE, MAPK and NF-κB Pathways